Preventing Complications in Pregnant Women with Mild and Moderate Severity of Acute Respiratory Infections

Relevance. Pregnant women are often exposed to respiratory viruses. Occasionally, the fetus may be harmed by the virus.

Goal to present materials revealing the safety and effectiveness of local interferon therapy used in the initial stage of acute respiratory infection in pregnant women from 14 weeks of gestation.

Materials and methods. An in-depth analysis of the results of a study of the safety and efficacy of local interferon-therapy of respiratory infections presented in more than 60 literature sources, and own research.

Results. It is shown that the inclusion of interferon-α2b (Viferon®) preparation in the complex of basic ARI therapy in pregnant women leads to a decrease in the content in the nasal washout of IL-8, the growth of T-lymphocytes and T-helpers, a more pronounced tendency to decrease natural killers; positively affects the microbiocenosis of the mucous membranes of the upper respiratory tract; leads to a reduction in symptoms of acute pharyngitis, bacterial complications from the upper respiratory tract and, as a consequence, minimizes the need for systemic antibacterial therapy.

Conclusions. The conclusion is made about the expediency of including the recombinant interferon-α2b (Viferon®) preparation in intranasal gel form in the complex of basic ARI therapy in pregnant women. 

1. Bocharova I. I., Kostinov M. P., Novikova S. V., Shmit’ko A. D, Obidina A. A., Tsivtsivadze E. B. Transplacental antibodies to measles virus in newborns in different pregnancy in their mothers. Rossiyskiy vestnik akushera-ginekologa. [Russian Bulletin of Obstetrician-Gynecologist]. 2014; 2 (14): 14–18.

2. Shmit’ko A. D., Novikova S. V., Bocharova I. I., Yakubina A. A., Kostinov M. P. et al. Mechanisms and factors affecting the transplacental transmission of IgG antibodies in the mother-placenta-fetus system. Rossiyskiy vestnik akushera-ginekologa. [Russian Bulletin of Obstetrician-Gynecologist]. 2014; 6 (14): 27–31.

3. Kostinov M. P., Cherdantsev A. P., Semenova S. S., Tarbaeva D. A., Savis’ko A. A., Serova O. F. et al. Obstetric and perinatal outcomes after vaccination against influenza or respiratory infection. Ginegologiya. [Gynecology]. 2015; 3 (14): 43–46.

4. Zaitsev A. A., Gorelov A. V., Klochkov O. I. Acute respiratory viral infections: perspectives of antiviral therapy. Vestnik semeinoi medicini. [Herald of Family Medicine]. 2009; 5: 18–23.

5. Sinopalnikov A. I. The Common Cold. Community-acquired infections of the respiratory tract. Moscow. Premier MT-Our City; 2007: 131–144.

6. Wiselka M. J., Nicholson K. G., Kent J., Cookson J. B., Tyrrell D. A. Prophylactic intranasal alpha 2 interferon and viral exacerbations of chronic respiratory disease. Thorax. 1991; 46: 706–711.

7. Khan M. A., Mikitchenko N. A., Chervinskaya A. V. Dynamics of mucosal immunity indices, cytobacteriological and morphofunctional state of the mucous oropharyngeal mucosa in children with frequent pain under the influence of halotherapy. Allergology and immunol. in pediatrics. Part I. Allergologiya i immunologia v pediatrii. [Allergology and Immunology in Pediatrics]. Part II. 2011; 1 (24): 33 –36; Часть II. 2011; 2 (25): 30–34.

8. Novikov D. K., Vykhristenko L. R., Novikov P. D. Immunology and allergology for ENT doctors: A guide for physicians. Ed.: D. K. Novikov. Moscow: Medical Information Agency. 2006: 512.

9. Palchun V. T., Kafarskaya L. I., Kunelskaya N. L., Artemiev M. E., Gurov A. V. Microbial landscape and ways of rational antibiotic therapy in acute purulent diseases of the ENT organs. Lechebnoje delo [General Medicine]. 2004; 4: 88–95.

10. Bartlett J. G. IDCP guidelies: management of upper respiratory tract infections. Infect. Dis. Clin. Practice. 1997; 6: 212–220.

11. Miravitlles M., Espinosa C., Fernandes-Laso E., Martos J. A., Maldonado J. A., Gallego M. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 1999; 116: 40–46.

12. Andrianova E. N., Snegireva N. Yu., Ryvkin A. I. Dysbiosis of the upper respiratory tract and changes in the functional state of respiratory organs in children are often sick. Pediatria. Zhurnal imeni Speranskogo. [Journal «Pediatria» named after G.N. Speransky]. 2009; 2: 35–39.

13. Izvin A. I., Kataeva L. V. The microbial landscape of the mucous membrane of the upper respiratory tract in norm and pathology.Vestnik otorinolaringologii. [Bulletin of Otorhinolaryngology 2009; 2: 65–68.

14. Pal’chun V. T., Kafarskaia L. I., Polyakova T. S., Gurov A. V. Dynamic investigation of the antibiotic resistance of the microbial background in the otorhinolaryngological department. Vestnik otorinolaringologii. [Bulletin of Otorhinolaryngology]. 2004; 1: 53–56.

15. Pan’kov A. S. Bacterial complications of influenza and their prediction. Izvestiya samarskogo nauchnogo centra RAN. [News of the Samara Scientific Center of the Russian Academy of Sciences]. 2012; том 14; 5 (2): 490–493.

16. Ermolina G. B., Belyaeva E. V., Degteva G. K., Menkov N. V., Boriskina E. V. Features of the microflora of the respiratory tract in various respiratory diseases. Nizhegorodsky medicinsky zhurnal. [Nizhny Novgorod Medical Journal]. 2004; 1: 17–21.

17. Zatsiorskaya S. L., Bashmakova M. A., Kalashnikova E. P. Generalized infection of the fetus and newborn caused by Group B streptococci. Voprosy Okhrany Materinstva i Detstva [Problems of Maternity and Child Care]. 1987: 60–62.

18. Lopatin A. S. Diagnosis and treatment of rhinitis and rhinosinusitis in pregnant women. Rossiyskiy allergologicheskiy zhurnal. [Russian Allergology Journal]. 2006; 1. Available at: http://www.allergy-journal.ru/journals/2006/1.

19. Grigorieva A. A. The role of interferon in the onset and treatment of acute purulent sinusitis. Doctorate of med. sci. diss. Moscow. 2004: 143.

20. Davis P. A., Gotefors L. A. Bacterial infections of fetus and newborn. A. G. Rumyantsev transl. from english.. Moscow. Medicine; 1987: 496.

21. Kudin AP, Marzal E. Yu. Clinical features and etiotropic treatment of meningitis caused by Streptococcus agalactiae in children. Medical Journal. 2012; 3: 135–138.

22. Berner R. Infektionen durch Gruppe-B-Streptokokken in der Neonatalperiode. Monatsschr. Kinderheild. 2003; 151: 373–383.

23. Heath P. T., Balfour G. F., Tighe H., Verlander N. Q., Lamagni T. L., Efstratiou A. Group B streptococcal disease in infants: a case control study. Arch. Dis. Child. 2009; 39: 674–680.

24. Prevention of perinatal group B streptococcal disease: Revised guidelines from CDC, 2010. MMWR. 2010; 59 (RR 10): 1–32.

25. Kostinov M. P., Meshcheryakova A. K., Foshina E. P., Tarbaeva D. A., Savisko A. A., Zaitseva E. V. Clinical course of acute respiratory infection and microbiocenosis of the upper respiratory tract in pregnant women. Zhurnal mikrobiologii, epidemiilogii i immunologii. [Journal of Microbiology Epidemiology and Immunobiology]. 2012; 5: 12–16.

26. Meshcheryakova A. K., Kostinov M. P., Magarshak O. O., Zaytseva E. V. Species and quantitative characteristics of the microflora of the mucous membrane of the pharynx in pregnant women. Zhurnal mikrobiologii, epidemiilogii i immunologii. [Journal of Microbiology Epidemiology and Immunobiology]. 2014; 2: 93–97.

27. Kilsenbaeva F. A. State of local immunity of the mucous membranes of the upper respiratory tract in norm and with inflammation. Doctorate of med. sci. diss. Ufa. 2002: 24.

28. Tsyvkina A. A., Luss L. V., Tsarev S. V. Mucosal immunity in the pathology of the upper respiratory tract. Rossiyskiy allergologicheskiy zhurnal. [Russian Allergology Journal]. 2011; 2: 22–26.

29. Mestecky J., Russell M. W., Elson Ch. O. Perspectives on Mucosal Vaccines: Is Mucosal Tolerance a Barrier? The Journal of Immunology. 2011: 5634–5637.

30. Mellert T. K., Gatchell M. L., Sparks L., Getchellet T. V. Characterization of the immune barrier in human olfactory mucosa. Otolaryng. Head. Neck. Surg. 1992; 106 (2): 181–188.

31. Bykova V. P. Mucous membrane of the nose and paranasal sinuses as the immune barrier of the upper respiratory tract. Rossiyskaya Rinologiya. [Russian Rhinology]. 1993; 1: 40–46.

32. Den’gin V. V., Delenyan N. V. Viferon: use in infectious and inflammatory diseases. Farmateka. [Pharmateca]. 2005; 12: 53–57.

33. Kolobukhina LV Viferon in the treatment and prevention of acute respiratory viral infections. Zhurnal mikrobiologii, epidemiilogii i immunologii. [Journal of Microbiology Epidemiology and Immunobiology]. 2003; 11 (5): 306.

34. Krivopustov S. P. Intranasal application of recombinant interferon alfa in pediatrics. Zdorovje Ukraini. [Health of Ukraine]. 2010; 1: 32.

35. Zakharova I. N., Torshkhoyeva L. B., Zaplatnikov A. L., Korovina N. A., Malinovskaya V. V., Chebotareva T. A. et al. Features of the interferon system in acute respiratory infections and clinical-immunological efficacy modified interferon therapy in young children. Effective pharmacotherapy. Pediatria. Zhurnal imeni Speranskogo. [Journal «Pediatria» named after G.N. Speransky]. 2011; 1: 70–73.

36. Akimkin V. G., Korotchenko S. I., Shevtsov V. A., Volgin A. R., Salmina T. A., Kalabukhova L. Yu. et al. Epidemiological and immunological efficacy of the drug viferon, gel for the prevention of influenza and other acute respiratory infections in organized military collectives. Epidemiologiya i infektsionnye bolezni. Aktualnye voprosy. [Epidimiology and Infectious Diseases. Current Issues]. Available at: http://www.epidemiology-journal.ru/ru/archive/article/11365 jn 20.01.2014.

37. Kurbanova Kh. I. Clinical and immunological grounds for local interferon therapy for respiratory viral infections in children. Doctorate of med. sci. diss. Moscow; 2012: 36.

38. Meshcheryakova A. K., Kostinov M. P., Magarshak O. O., Guseva T. S., Parshina O. V., Parfenov V. V. et al. Indices of local immunity in pregnant women with acute respiratory infection against interferon therapy. Voprosi ginekologii, akusherstva i perinatologii. [Gynecology, Obstetrics and Perinatology]. 2014; том 13; 2: 44–46.

39. Malinovskaya V. V., Mazankova L. N., Korovina N. A., Kurbanova Kh. I., Glukhareva N. S., Koroid N. V. Current possibilities of using interferons in complex therapy of acute respiratory infections in children. Lechaschii Vrach. [Lechaschii Vrach Journal].2011: 8.

40. Chernushevich I. I. Clinical and immunological basis for the use of recombinant interleukin-1 beta (Betaleukina) in the treatment of patients with chronic purulent otitis media. Doctorate of med. sci. diss. St. Petersburg; 2000: 24.

41. Khushukoyeva A. Z., Ibragimova M. I., Khashukoyeva Z. Z., Burdenko M. V. Possibilities of using Viferon (PHERON) in obstetric-gynecological practice.Effektivnaya farmakoterapia. Akusherstvo i ginekologia. [Effective pharmacotherapy. Obstetrics and gynecology]. 2007; 4: 23–27.

42. Aleshkin V. A., Lozhkina A. N., Zagorodnyaya E. D. Immunology of reproduction: a manual for physicians, attending physician and researchers. Chita. 2004: 79.

43. Khonina N. A. Manifestations and mechanisms of the formation of immunosuppression at various stages of the reproductive process in norm and in pathology. PhD of med. sci. diss. 2007: 195.

44. Matthiesen L., Khademi M., Ekerfelt C., Berg G. In situ detection of both inflammatory and anti-inflammatory cytokines in resting peripheral blood mononuclear cells during pregnancy. J. Reprod. Immunol. 2003; 58: 49–59.

45. Sakai M., Tsuda H., Tanebe К. Sasaki Ya., Saito Sh. Interleukin-12 secretion by peripheral blood mononuclear cells is decreased in normal pregnant subjects and increased in preeclamptic patients.Am. J. Reprod. Immunol. 2002; 47: 91–92.

46. Sukhikh G. T., Vanko L. V. Immunology of pregnancy. Moscow.2003: 400.

47. Kostinov M. P., Khromova E. A., Savis’ko A. A., Kostinova A. M. Functional features of the immune system in the physiological course of pregnancy and their relationship with vaccination against influenza. Consilium Medicum. 2016; Volume 18; 6: 59–62.

48. Obraztsova E. V., Osidak L. V., Golovacheva Ye. G. Interferon status in children with acute respiratory infections. Interferonotherapy.Bulleten’ experimental’noi biologii i medicini. [Bulletin of Experimental Biology and Medicine]. 2009; 8: 22–26.

49. Leont’eva G. M. Features of immunopathological manifestations of acute rhinosinusitis in the gestational period. Doctorate of med. sci. diss. 2009: 102.

50. Kostinov M. P., Lukachev I. V., Meshcheryakova A. K., Dmitrieva Ye. V., Akhmatova N. K., Khromova E. A. et al. Induction of the effectors of congenital and adaptive immunity in the treatment with the topical form of the recombinant interferon-α2b for respiratory infections in pregnant women. Zhurnal mikrobiologii, epidemiilogii i immunologii. [Journal of Microbiology Epidemiology and Immunobiology]. 2017; 2: 38–45.

51. Meshcheryakova A. K., Kostinov M. P., Kytko O. V., Malinovskaya V. V., Tarbaeva D. A., Nikonova A. A. et al. Clinical effect of the use of various medicinal forms of Viferon in pregnant women with acute respiratory infection. Effektivnaya farmakoterapia. Akusherstvo i ginekologia. [Effective pharmacotherapy. Obstetrics and gynecology]. 2010; 4: 46–49.

52. Meshcheryakova A. K., Kostinov M. P., Magarshak O. O., Guseva T. S., Parshina O. V. Influence of the preparation of recombinant interferon α-2b in the form of gel on the ARI and the state of mucosal immunity in women in the 14 weeks gestation. Vestnik otorinolaringologii. [Bulletin of Otorhinolaryngology]. 2014; 6: 50–53.

53. Afinogenova V. P., Lukachev I. V., Kostinov M. P. Immunotherapy: mechanism of action and clinical use of immunocorrecting drugs. Lechaschii Vrach. [Lechaschii Vrach Journal]. 2010; 4: 9.

54. Federal guidance on the use of medicines (formular system, reference publication). Issue XVII, Ed.: A. G. Chuchalin, V. V. Yasnetsov. Moscow. Widox. 2016: 745–768.

55. Allergology and Immunology. National leadership. Ed.: R. M Haitov, N. I. Il’ina. Moscow. GEOTAR-Media. 2014: 656.

56. Clinical and immunological efficacy of immunobiological preparations. Reference book. Ed.: M. P. Kostinov, N. A. Ozeretskovsky. Moscow. Miklosh. 2004: 256.2004: 256.

57. Averyanov A. V., Babkin A. P., Bart B. Ya., Volchetzky A. L., Minina E. S., Kozyrev O. A. et al. Ergoferon and oseltamivir in the treatment of influenza - the results of a multicenter, comparative, randomized clinical research.Antibiotiki i himioterahia. [Antibiotics and Chemotherapy]. 2012. 7–8 (57): 23–30.

58. Gurevich K. G. Development of intranasal drug delivery systems.Kachestvennaia klinicheskaia praktika. [Good Clinical Practice]. 2002; 1.

59. Hayden F. G., Albrecht J. K., Kaiser D. L. Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. N. Engl. J. Med. 1986; 314 (2): 71–75.

60. Jefferson T. O., Tyrrell D. Antivirals for the common cold. The Cochrane Database of Systematic Reviews. 2005; Issue 3.

61. Alpenidze D. N., Borzanova M. V., Maklakova E. V., Romanova M. V., Chernyaeva E. V. Modern approaches to adult acute respiratory viral therapy in adults: results of a clinical study of nasal spray interferon α. Reference book to polyclinic doctor. 2010; 9.